De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

ISC Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

ISC heeft een totaal eigen vermogen van ₩500.7B en een totale schuld van ₩31.4B, wat de schuld-eigenvermogensverhouding op 6.3% brengt. De totale activa en totale passiva bedragen respectievelijk ₩572.4B en ₩71.7B. De EBIT ISC is ₩17.9B waardoor de rentedekking -2.3 is. Het heeft contanten en kortetermijnbeleggingen van ₩315.1B.

Belangrijke informatie

6.3%

Verhouding schuld/eigen vermogen

₩31.43b

Schuld

Rente dekkingsratio	-2.3x
Contant	₩315.12b
Aandelen	₩500.73b
Totaal verplichtingen	₩71.67b
Totaal activa	₩572.40b

Recente financiële gezondheidsupdates

Is ISC (KOSDAQ:095340) A Risky Investment?

Feb 01

Recent updates

ISC Co., Ltd. (KOSDAQ:095340) Shares Slammed 30% But Getting In Cheap Might Be Difficult Regardless

Aug 05

We Think ISC's (KOSDAQ:095340) Profit Is Only A Baseline For What They Can Achieve

Mar 26

Can ISC (KOSDAQ:095340) Continue To Grow Its Returns On Capital?

Mar 02

Is ISC (KOSDAQ:095340) A Risky Investment?

Feb 01

Do Institutions Own ISC Co., Ltd. (KOSDAQ:095340) Shares?

Jan 13

Do Its Financials Have Any Role To Play In Driving ISC Co., Ltd.'s (KOSDAQ:095340) Stock Up Recently?

Dec 23

If You Had Bought ISC (KOSDAQ:095340) Shares A Year Ago You'd Have Earned 123% Returns

Dec 02

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( ₩390.9B ) A095340 } overtreffen de korte termijn passiva ( ₩64.2B ).

Langlopende schulden: De kortetermijnactiva A095340 ( ₩390.9B ) overtreffen de langetermijnschulden ( ₩7.5B ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: A095340 heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van A095340 is de afgelopen 5 jaar gedaald van 8% naar 6.3%.

Schuldendekking: De schuld van A095340 wordt goed gedekt door de operationele kasstroom ( 102.8% ).

Rentedekking: A095340 verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.

ISC Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Is ISC (KOSDAQ:095340) A Risky Investment?

Recent updates

Now 20% undervalued after recent price drop

ISC Co., Ltd. (KOSDAQ:095340) Shares Slammed 30% But Getting In Cheap Might Be Difficult Regardless

Consensus EPS estimates fall by 10%

Now 21% undervalued after recent price drop

Why ISC Co., Ltd. (KOSDAQ:095340) Could Be Worth Watching

Price target decreased by 9.4% to ₩106,375

Now 22% undervalued after recent price drop

Now 21% undervalued after recent price drop

A Look At The Fair Value Of ISC Co., Ltd. (KOSDAQ:095340)

ISC (KOSDAQ:095340) Will Be Hoping To Turn Its Returns On Capital Around

Why ISC's (KOSDAQ:095340) Shaky Earnings Are Just The Beginning Of Its Problems

Full year 2023 earnings released: EPS: ₩749 (vs ₩2,526 in FY 2022)

ISC Co., Ltd.'s (KOSDAQ:095340) 32% Price Boost Is Out Of Tune With Revenues

Now 20% overvalued

A Look At The Intrinsic Value Of ISC Co., Ltd. (KOSDAQ:095340)

Upcoming dividend of ₩600 per share at 0.7% yield

Third quarter 2023 earnings released: ₩275 loss per share (vs ₩964 profit in 3Q 2022)

Consensus EPS estimates increase by 18%, revenue downgraded

Investor sentiment improves as stock rises 20%

New minor risk - Shareholder dilution

Consensus EPS estimates fall by 11%

ISC Co., Ltd. announced that it has received KRW 199.999919355 billion in funding from Helios Private Equity, SKC Co., Ltd.

Investor sentiment deteriorates as stock falls 15%

Investor sentiment improves as stock rises 17%

New minor risk - Share price stability

Price target increased by 19% to ₩61,000

Investor sentiment improves as stock rises 20%

Investor sentiment improves as stock rises 30%

Now 20% undervalued

Now 20% undervalued

Now 21% undervalued

Investor sentiment improves as stock rises 16%

Upcoming dividend of ₩200 per share

No independent directors

Investor sentiment improved over the past week

No independent directors

Investor sentiment improved over the past week

ISC Co., Ltd. announced that it has received KRW 13.4769495 billion in funding from Helios Private Equity Co., Ltd., Mason Cactus Innovation Growth Investment Association No. 1

ISC Co., Ltd. announced that it has received KRW 13.4769495 billion in funding from Helios Private Equity Co., Ltd., Mason Cactus Innovation Growth Investment Association No. 1

ISC Co., Ltd. announced that it expects to receive KRW 13.4769495 billion in funding from Helios Private Equity Co., Ltd., Mason Cactus Innovation Growth Investment Association No. 1

Now 24% undervalued

Upcoming dividend of ₩150 per share

Investor sentiment improved over the past week

ISC Co., Ltd. announced that it has received KRW 6.5230505 billion in funding

ISC Co., Ltd. (KOSDAQ:A095340) announces an Equity Buyback for KRW 135 million worth of its shares.

ISC Co., Ltd. announced that it expects to receive KRW 6.5230505 billion in funding

Investor sentiment improved over the past week

Calculating The Fair Value Of ISC Co., Ltd. (KOSDAQ:095340)

We Think ISC's (KOSDAQ:095340) Profit Is Only A Baseline For What They Can Achieve

Investor sentiment improved over the past week

New 90-day low: ₩19,100

Can ISC (KOSDAQ:095340) Continue To Grow Its Returns On Capital?

ISC Co., Ltd., Annual General Meeting, Mar 26, 2021

Is ISC (KOSDAQ:095340) A Risky Investment?

Investor sentiment deteriorated over the past week

New 90-day high: ₩27,950

Do Institutions Own ISC Co., Ltd. (KOSDAQ:095340) Shares?

New 90-day high: ₩27,000

Do Its Financials Have Any Role To Play In Driving ISC Co., Ltd.'s (KOSDAQ:095340) Stock Up Recently?

Upcoming Dividend of ₩50.00 Per Share

Market bids up stock over the past week

New 90-day high: ₩23,300

If You Had Bought ISC (KOSDAQ:095340) Shares A Year Ago You'd Have Earned 123% Returns

New 90-day low: ₩17,300

Market pulls back on stock over the past week

New 90-day high - ₩22,600

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven